A citation-based method for searching scientific literature

Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle, Uli C Broedl, Silvio E Inzucchi. N Engl J Med 2015
Times Cited: 5710



William Duckworth, Carlos Abraira, Thomas Moritz, Domenic Reda, Nicholas Emanuele, Peter D Reaven, Franklin J Zieve, Jennifer Marks, Stephen N Davis, Rodney Hayward, Stuart R Warren, Steven Goldman, Madeline McCarren, Mary Ellen Vitek, William G Henderson, Grant D Huang. N Engl J Med 2009
Times Cited: 3106




List of shared articles



Times cited

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
Frank L J Visseren, François Mach, Yvo M Smulders, David Carballo, Konstantinos C Koskinas, Maria Bäck, Athanase Benetos, Alessandro Biffi, José-Manuel Boavida, Davide Capodanno,[...]. Eur J Prev Cardiol 2022
18

13. Older Adults: Standards of Medical Care in Diabetes-2022.
Boris Draznin, Vanita R Aroda, George Bakris, Gretchen Benson, Florence M Brown, RaShaye Freeman, Jennifer Green, Elbert Huang, Diana Isaacs, Scott Kahan,[...]. Diabetes Care 2022
4

Adherence to the American Diabetes Association's Glycemic Goals in the Treatment of Diabetes Among Older Americans, 2001-2018.
Phuc Le, Gina Ayers, Anita D Misra-Hebert, Shoshana J Herzig, William H Herman, Victoria A Shaker, Michael B Rothberg. Diabetes Care 2022
0

SGLT2 Inhibitors: Benefits for CKD and Cardiovascular Disease in Type 2 Diabetes.
Rohit Singhal, Lisa Aimee Hechanova. Curr Cardiol Rep 2022
0

Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes.
Oliver Schnell, Tadej Battelino, Richard Bergenstal, Matthias Blüher, Michael Böhm, Frank Brosius, Richard D Carr, Antonio Ceriello, Thomas Forst, Francesco Giorgino,[...]. Cardiovasc Diabetol 2022
0

The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases.
Aikaterini Andreadi, Alfonso Bellia, Nicola Di Daniele, Marco Meloni, Renato Lauro, David Della-Morte, Davide Lauro. Curr Opin Pharmacol 2022
3

Heterogeneous treatment effects of intensive glycemic control on major adverse cardiovascular events in the ACCORD and VADT trials: a machine-learning analysis.
Justin A Edward, Kevin Josey, Gideon Bahn, Liron Caplan, Jane E B Reusch, Peter Reaven, Debashis Ghosh, Sridharan Raghavan. Cardiovasc Diabetol 2022
0